Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record and navigation with an access-denied screen. This indicates a restriction or system issue that prevents viewing the trial details.
    Difference
    18%
    Check dated 2026-09-20T20:04:04.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing the previous Revision: v3.6.5 in the footer, indicating a recent update to the page metadata. This update does not modify study content or visible data, but refreshes the document version tracked by the site.
    Difference
    0.1%
    Check dated 2026-08-30T21:39:09.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now lists sponsor and collaborators (e.g., Washington University School of Medicine and NovoCure Ltd.) and adds links to essential documents (Study Protocol and Statistical Analysis Plan) plus related terminology, expanding the contextual resources for this trial.
    Difference
    50%
    Check dated 2026-08-16T14:55:58.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.5, replacing v3.6.4. This indicates a minor maintenance update to the page rather than a change to study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-09T09:19:08.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This change represents an internal update to the page's versioning or display framework rather than a modification to the study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-25T18:00:41.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small backend/content management update. There are no changes to the study data or displayed details.
    Difference
    0.1%
    Check dated 2026-07-04T13:29:14.000Z thumbnail image

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.